Results 61 to 70 of about 843,336 (254)

Long‐Term (5‐Years) Outcomes of Current Drug‐Eluting Stents in Percutaneous Coronary Intervention: A Network Meta‐Analysis of Randomized Controlled Trials

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Various drug‐eluting stents (DES) are currently used for percutaneous coronary intervention (PCI). However, long‐term trials reveal inconsistent results in head‐to‐head comparisons. Aims To conduct a network meta‐analysis of relevant trials to assess the performance of different DES currently used in PCI.
Aman Goyal, Humza Saeed, Sonia Hurjkaliani, Yusra Mashkoor, Abdullah, Gauranga Mahalwar, Ankur Kalra, Grant W. Reed   +7 more
wiley   +1 more source

Restenosis and progression of coronary atherosclerosis after coronary angioplasty

Journal of the American College of Cardiology, 1988
The relation between restenosis and progression of atherosclerosis in other coronary segments after angioplasty was studied in 98 consecutive patients with 110 coronary stenoses successfully treated with angioplasty. At early angiographic restudy (5 +/- 2 months after angioplasty) 37 patients (38%) had restenosis (defined as a stenosis greater than or ...
Angel Cequier, Raoul Bonan, Patrick Joly, Jacques Lespérance, Pierre de Guise, David D. Waters, Jacques Crépeau, Gilles Côté   +7 more
openaire   +3 more sources

A paclitaxel-eluting stent for the prevention of coronary restenosis.

New England Journal of Medicine, 2003
BACKGROUND Intimal hyperplasia and resulting restenosis limit the efficacy of coronary stenting. We studied a coronary stent coated with the antiproliferative agent paclitaxel as a means of preventing restenosis.
Seung‐Jung Park, W. Shim, D. Ho, A. Raizner, Seong-Wook Park, M. Hong, Cheol-Whan Lee, D. Choi, Y. Jang, Ricky Lam, N. Weissman, G. Mintz   +11 more
semanticscholar   +1 more source

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

BMC Cardiovascular Disorders, 2009
Background Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the ...
Lankisch Mark, Haltern Georg, Huge Andreas, Rackebrandt Kirsten, Binner Priska, Kullmann Silke, Füth Reiner, von Hodenberg Eberhard, Bestehorn Hans-Peter, Scheffold Thomas   +9 more
doaj   +1 more source

The Current State of MicroRNAs as Restenosis Biomarkers

Frontiers in Genetics, 2020
In-stent restenosis corresponds to the diameter reduction of coronary vessels following percutaneous coronary intervention (PCI), an invasive procedure in which a stent is deployed into the coronary arteries, producing profuse neointimal hyperplasia. The
Nelson Varela, Fernando Lanas, Fernando Lanas, Luis A. Salazar, Tomás Zambrano   +4 more
doaj   +1 more source

Drug Coated Balloon in Young Patients With ST‐Elevation Myocardial Infarction: A Viable Treatment Option?

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT This clinical case highlights the safety and feasibility of drug coated balloon (DCB) angioplasty in a very young patients presenting with STEMI (ST‐Elevation Myocardial Infarction) to avoid long‐term complications associated with stent implantation, which still amount to 1%−2%.
Davor Vukadinović, Saarraaken Kulenthiran, Felix Mahfoud, Bruno Scheller   +3 more
wiley   +1 more source

Silent Danger: Coexistence of Late‐Onset External Iliac Artery Pseudoaneurysm and Deep Vein Thrombosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Pseudoaneurysm (PA) is a well‐known vascular complication following percutaneous interventions, typically occurring in the early post‐procedural period. However, delayed‐onset PA associated with deep vein thrombosis (DVT) is an uncommon presentation.
Sefa Tatar, Oznur Keskin, Abdullah Enes Atas, Abdullah Icli   +3 more
wiley   +1 more source

Intractable coronary fibromuscular dysplasia leading to end‐stage heart failure and fatal heart transplantation

ESC Heart Failure, 2020
Coronary fibromuscular dysplasia is uncommon, and even rarer its unstable and recurrent course. We present the unique case of a 52‐year‐old woman who underwent in total 12 coronary angiographies and three percutaneous coronary intervention within 24 ...
Magdalena Maria Cattaneo, Marco Moccetti, Mattia Cattaneo, Daniel Sürder, Thomas Suter, Michele Martinelli, Eva Roost, Jürg Schmidli, Yara Banz, Carmen Schneiders, Giovanni Pedrazzini, Roberto Corti, Lorenz Räber, Filippo Crea, Paul Mohacsi, Augusto Gallino   +15 more
doaj   +1 more source

Efficacy of Direct Injection in Occlusive Lesion (DIOL) Fashion for Infrapopliteal and Inframalleolar Chronic Total Occlusions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Endovascular therapy (EVT) for chronic total occlusions (CTOs) in patients with critical limb‐threatening ischemia (CLTI) remains technically challenging, particularly in infrapopliteal lesions. Direct injection in occlusive lesions (DIOL) fashion is a novel adjunctive strategy that utilizes hydraulic contrast injection through a ...
Takuya Haraguchi, Tsutomu Fujita, Masanaga Tsujimoto, Yuhei Kasai, Yoshifumi Kashima, Katsuhiko Sato   +5 more
wiley   +1 more source

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

European Heart Journal, 2009
Aims The purpose of this study was to evaluate the GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberté paclitaxel-eluting stent in patients with de novo coronary lesions with a high-risk of coronary restenosis.
M. Beijk, M. Klomp, N. Verouden, N. van Geloven, K. Koch, J. Henriques, J. Baan, M. Vis, Esther M. Scheunhage, J. Piek, J. Tijssen, R. D. de Winter   +11 more
semanticscholar   +1 more source